StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
122
This month
1
This year
11
Publishing Date
2024 - 03 - 27
2
2023 - 12 - 08
2
2023 - 05 - 31
2
2023 - 05 - 15
3
2022 - 09 - 13
2
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 08 - 04
1
2022 - 08 - 02
2
2022 - 07 - 15
1
2022 - 07 - 04
2
2022 - 06 - 10
1
2022 - 06 - 04
1
2022 - 05 - 24
1
2022 - 05 - 12
1
2022 - 04 - 26
1
2022 - 04 - 19
1
2022 - 04 - 13
1
2022 - 03 - 31
1
2022 - 03 - 28
1
2022 - 03 - 16
1
2022 - 03 - 15
1
2022 - 03 - 08
1
2022 - 02 - 18
1
2022 - 02 - 15
1
2022 - 02 - 10
1
2022 - 02 - 07
1
2022 - 01 - 14
1
2022 - 01 - 04
1
2021 - 12 - 15
1
2021 - 12 - 08
1
2021 - 11 - 11
1
2021 - 09 - 24
1
2021 - 08 - 31
1
2021 - 08 - 25
1
2021 - 08 - 23
1
2021 - 08 - 19
1
2021 - 08 - 12
1
2021 - 08 - 10
1
2021 - 08 - 06
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 07 - 12
1
2021 - 07 - 08
1
2021 - 06 - 29
1
2021 - 06 - 24
1
2021 - 06 - 17
1
2021 - 06 - 04
1
2021 - 05 - 17
1
2021 - 05 - 06
1
2021 - 04 - 21
1
2021 - 04 - 13
1
2021 - 04 - 09
1
2021 - 04 - 06
1
2021 - 03 - 31
1
2021 - 03 - 24
1
2021 - 03 - 22
1
2021 - 03 - 16
1
Sector
Communications
1
Electronic technology
1
Finance
3
Health services
1
Health technology
122
Manufacturing
9
N/a
4
Process industries
1
Professional, scientific, and technical services
1
Technology services
1
Tags
Acquired
1
Antiviral
6
Application
5
Approval
6
Aviptadil
2
Awards
3
Biopharma
2
Biotech
4
Breast cancer
11
Cancer
20
Car-t
2
China
5
Collaboration
2
Covid
4
Covid-19
5
Designation
2
Diagnostics
2
Disease
5
Drug
15
Ema
2
Expansion
3
Fda
3
Financial
2
Gene therapies
2
Gene therapy
2
Global
28
Growing
4
Growth
9
Health
4
Hepatitis
2
Hiv
10
Hypertension
3
Impact
4
Iot
5
Leukemia
3
License
2
Market
48
N/a
122
Negative
3
New drug
2
Partnership
2
Payment
2
Phase 2
2
Potential
3
Pre-clinical
2
Preclinical
2
Reach
6
Report
18
Research
14
Results
7
Sciences
5
Study
3
T-cell
5
Technology
5
Therapeutics
7
Therapy
18
Treatment
11
Trial
4
Trodelvy
5
Women
2
Entities
Abbott laboratories
6
Abbvie inc.
26
Abeona therapeutics inc.
2
Adaptimmune therapeutics plc
3
Alnylam pharmaceuticals, inc.
3
Amgen inc.
15
Applied genetic technologies corporation
2
Arcellx, inc.
3
Astellas pharma inc
3
Astrazeneca plc
9
Athenex, inc.
2
Autolus therapeutics plc
2
Baxter international inc.
3
Becton, dickinson and company
2
Bellicum pharmaceuticals, inc.
2
Biogen inc.
6
Bluebird bio, inc.
4
Boston scientific corporation
2
Bristol-myers squibb company
30
Calliditas therapeutics ab
2
Catalent, inc.
2
Celyad oncology sa
2
Crispr therapeutics ag
3
Editas medicine, inc.
3
Eiger biopharmaceuticals, inc.
2
Eli lilly and company
18
Exelixis, inc.
2
Genmab a/s
4
Gilead sciences, inc.
122
Glaukos corporation
2
Glaxosmithkline plc
21
Global blood therapeutics, inc.
2
Illumina, inc.
2
Immunogen, inc.
2
Intellia therapeutics, inc.
3
Johnson & johnson
37
Karyopharm therapeutics inc.
2
Novartis ag
28
Novo nordisk a/s
8
Nrx pharmaceuticals inc
2
Orchard therapeutics plc
2
Pfizer, inc.
10
Poseida therapeutics, inc.
2
Regeneron pharmaceuticals, inc.
5
Regenxbio inc.
2
Sangamo therapeutics, inc.
3
Sanofi
33
Sarepta therapeutics, inc.
4
Sorrento therapeutics, inc.
3
State street corporation
2
Takeda pharmaceutical company limited
15
Teva pharmaceutical industries limited
3
Teva pharmaceutical industries ltd
10
Thermo fisher scientific inc
4
Ucb s.a.
3
Uniqure n.v.
2
United therapeutics corporation
3
Vertex pharmaceuticals incorporated
6
Viatris inc.
5
Vir biotechnology, inc.
2
Symbols
AAPL
1042
ABB
1420
ABBV
684
ABLZF
1163
ABT
1521
ACN
591
ADBE
441
AMCR
445
AMGN
490
ARVL
2511
AVGO
543
BDX
647
BSX
488
CMI
516
CSCO
865
DELL
567
DHR
698
DNZOF
497
DNZOY
497
DOW
549
DUK
524
ERIC
1406
F
511
FE
517
FNCTF
4151
GE
841
GLAXF
566
GOOG
1058
GOOGL
1057
GSK
703
HON
1779
IBM
624
IFNNF
510
IFNNY
490
INTC
838
IT
463
JCI
479
JNJ
2169
LLY
859
LMT
550
MDT
1127
MMM
913
MS
1903
MSFT
1147
NIPNF
503
NVS
881
NVSEF
765
ORCL
1137
PCRFF
648
PCRFY
648
PHG
752
PPRUF
518
PPRUY
519
SAP
1440
SAPGF
1204
SNEJF
455
SNY
1612
SNYNF
1312
SPGI
486
TMO
1368
Exchanges
Nasdaq
122
Nyse
68
Crawled Date
2024 - 03 - 27
2
2023 - 12 - 08
2
2023 - 05 - 15
3
2022 - 09 - 13
2
2022 - 08 - 16
1
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 08 - 04
1
2022 - 08 - 02
2
2022 - 07 - 15
1
2022 - 07 - 04
2
2022 - 06 - 10
1
2022 - 06 - 04
1
2022 - 05 - 24
1
2022 - 05 - 12
1
2022 - 04 - 26
1
2022 - 04 - 19
1
2022 - 04 - 13
1
2022 - 03 - 31
1
2022 - 03 - 28
1
2022 - 03 - 16
1
2022 - 03 - 15
1
2022 - 03 - 08
1
2022 - 02 - 18
1
2022 - 02 - 15
1
2022 - 02 - 10
1
2022 - 02 - 07
1
2022 - 01 - 14
1
2022 - 01 - 04
1
2021 - 12 - 15
1
2021 - 12 - 08
1
2021 - 11 - 11
1
2021 - 09 - 24
1
2021 - 08 - 31
1
2021 - 08 - 25
1
2021 - 08 - 23
1
2021 - 08 - 19
1
2021 - 08 - 12
1
2021 - 08 - 10
1
2021 - 08 - 06
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 07 - 12
1
2021 - 07 - 08
1
2021 - 06 - 29
1
2021 - 06 - 24
1
2021 - 06 - 17
1
2021 - 06 - 04
1
2021 - 05 - 17
1
2021 - 05 - 06
1
2021 - 04 - 21
1
2021 - 04 - 13
1
2021 - 04 - 09
1
2021 - 04 - 06
1
2021 - 03 - 31
1
2021 - 03 - 24
1
2021 - 03 - 22
1
2021 - 03 - 16
1
Crawled Time
00:00
5
01:00
9
02:00
1
03:00
3
04:00
2
04:20
1
06:00
1
07:00
1
08:00
3
09:00
2
10:00
2
11:00
13
12:00
5
12:20
3
13:00
1
13:15
1
13:20
4
13:30
1
14:00
8
14:15
1
14:20
3
14:30
2
15:00
4
15:15
1
15:20
1
15:30
2
16:00
5
16:20
1
17:00
6
18:00
7
19:00
4
20:00
5
21:00
6
22:00
4
23:00
4
Source
galmedpharma.com
1
investor.assemblybio.com
1
ir.voyagertherapeutics.com
1
www.biospace.com
274
www.fda.gov
19
www.globenewswire.com
80
www.igmbio.com
1
www.nurixtx.com
1
www.prnewswire.com
122
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
GILD
source :
Www.prnewswire.com
save search
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Published:
2024-04-08
(Crawled : 13:30)
- prnewswire.com
RDHL
|
$0.4249
-3.96%
310K
|
Health Technology
|
-16.82%
|
O:
0.57%
H:
0.0%
C:
-1.5%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-3.78%
|
O:
-0.76%
H:
0.72%
C:
0.54%
biopharma
results
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.38
0.54%
790K
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.885
-0.29%
190K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.85
1.49%
920K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.31
2.3%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$289.67
5.3K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$170.19
1.37%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023
Published:
2024-03-27
(Crawled : 23:00)
- prnewswire.com
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-8.3%
|
O:
0.33%
H:
0.85%
C:
0.0%
year
financial
results
Hepatitis B and C diagnostics market size to increase by USD 2.05 billion, Technavio
Published:
2024-03-27
(Crawled : 14:30)
- prnewswire.com
DHR
|
$253.88
7.54%
3.4M
|
Health Technology
|
-4.98%
|
O:
0.56%
H:
0.16%
C:
-0.43%
ABT
|
News
|
$108.01
0.88%
1.2M
|
Health Technology
|
-3.05%
|
O:
1.48%
H:
0.0%
C:
0.0%
VIR
|
$8.145
0.56%
180K
|
Health Technology
|
-18.76%
|
O:
0.4%
H:
2.3%
C:
0.9%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-7.54%
|
O:
0.7%
H:
0.19%
C:
0.12%
hepatitis
diagnostics
market
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published:
2024-03-18
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-2.31%
|
O:
-0.02%
H:
0.0%
C:
0.0%
BAX
|
$40.965
1.4%
810K
|
Health Technology
|
-2.74%
|
O:
0.02%
H:
1.03%
C:
0.96%
SNY
|
News
|
$47.85
1.49%
920K
|
Health Technology
|
-3.65%
|
O:
-1.51%
H:
0.0%
C:
0.0%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-8.61%
|
O:
0.11%
H:
0.59%
C:
0.1%
BIIB
|
$194.31
0.1%
470K
|
Health Technology
|
-11.53%
|
O:
-0.48%
H:
0.31%
C:
0.13%
reach
cancer
treatment
global
market
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Published:
2024-02-28
(Crawled : 21:00)
- prnewswire.com
ACLX
|
$55.43
6.6%
160K
|
|
-22.76%
|
O:
3.09%
H:
0.94%
C:
-5.16%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-7.91%
|
O:
0.03%
H:
0.26%
C:
-0.85%
business
financial
results
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
-7.54%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
News
|
$97.31
2.3%
2.3M
|
Health Technology
|
-7.81%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$741.37
1.37%
800K
|
Health Technology
|
-4.98%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
|
-4.27%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
News
|
$170.19
1.37%
1.6M
|
Health Technology
|
-5.01%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$47.85
1.49%
920K
|
Health Technology
|
-3.42%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-8.01%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
News
|
$273.38
0.54%
790K
|
Health Technology
|
-4.65%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
690K
|
Manufacturing
|
-11.92%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
|
-1.23%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$170.19
1.37%
1.6M
|
Health Technology
|
-2.99%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.85
1.49%
920K
|
Health Technology
|
0.16%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-10.07%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
$146.64
0.58%
200K
|
Health Technology
|
-13.91%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published:
2024-01-26
(Crawled : 15:30)
- prnewswire.com
TAK
|
News
|
$13.41
0.37%
1M
|
Health Technology
|
-8.68%
|
O:
-0.27%
H:
0.38%
C:
0.07%
NVS
|
News
|
$97.31
2.3%
2.3M
|
Health Technology
|
-11.42%
|
O:
0.29%
H:
0.15%
C:
-0.13%
SRPT
|
$118.24
1.09%
160K
|
Health Technology
|
-2.55%
|
O:
0.69%
H:
0.12%
C:
-1.75%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-16.55%
|
O:
0.0%
H:
0.35%
C:
-0.88%
AMGN
|
News
|
$273.38
0.54%
790K
|
Health Technology
|
-12.36%
|
O:
0.1%
H:
0.47%
C:
0.39%
market
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
|
News
A
|
$26.24
-0.08%
11M
|
Health Technology
|
-7.63%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
News
|
$97.31
2.3%
2.3M
|
Health Technology
|
-12.03%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.015
140K
|
Health Technology
|
-66.67%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-15.76%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.555
-0.11%
800K
|
Health Technology
|
-17.39%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published:
2024-01-17
(Crawled : 02:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
630
|
Health Technology
|
3.62%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.31
2.3%
2.3M
|
Health Technology
|
-12.0%
|
O:
0.49%
H:
0.18%
C:
0.04%
JNJ
|
News
|
$150.09
0.65%
3.9M
|
Health Technology
|
-7.91%
|
O:
-1.02%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.13
1.33%
1.1M
|
Health Technology
|
1.78%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABT
|
News
|
$108.01
0.88%
1.2M
|
Health Technology
|
-5.65%
|
O:
0.12%
H:
0.77%
C:
0.27%
SNY
|
News
|
$47.85
1.49%
920K
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-22.14%
|
O:
-0.19%
H:
0.87%
C:
0.76%
report
infection
treatment
global
market
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published:
2023-12-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-3.25%
|
O:
3.66%
H:
0.0%
C:
-0.12%
AZNCF
|
News
|
$138.73
3.7K
|
Health Technology
|
6.31%
|
O:
3.33%
H:
0.0%
C:
-2.93%
NVO
|
News
|
$128.31
2.44%
2.2M
|
Health Technology
|
21.05%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
JNJ
|
News
|
$150.09
0.65%
3.9M
|
Health Technology
|
-2.87%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
News
|
$741.37
1.37%
800K
|
Health Technology
|
27.85%
|
O:
0.18%
H:
0.5%
C:
-0.46%
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
|
-4.14%
|
O:
-0.78%
H:
5.15%
C:
2.81%
ABBV
|
News
|
$170.19
1.37%
1.6M
|
Health Technology
|
10.03%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.85
1.49%
920K
|
Health Technology
|
-5.04%
|
O:
1.03%
H:
0.0%
C:
0.0%
REGN
|
News
|
$908.42
0.92%
130K
|
Health Technology
|
6.92%
|
O:
0.52%
H:
0.58%
C:
0.05%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-15.18%
|
O:
0.34%
H:
1.02%
C:
0.59%
BIIB
|
$194.31
0.1%
470K
|
Health Technology
|
-23.54%
|
O:
0.57%
H:
1.36%
C:
1.04%
AZN
|
News
|
$70.87
1.06%
3M
|
Health Technology
|
5.78%
|
O:
1.06%
H:
0.18%
C:
-1.06%
AMGN
|
News
|
$273.38
0.54%
790K
|
Health Technology
|
-2.66%
|
O:
0.24%
H:
2.03%
C:
1.49%
patent
report
global
market
Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH
Published:
2023-12-08
(Crawled : 21:00)
- prnewswire.com
ACLX
|
$55.43
6.6%
160K
|
|
Email alert
Add to watchlist
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
Email alert
Add to watchlist
expansion
trial
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
200
|
Health Technology
|
-21.02%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
-1.82%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
News
|
$9.53
690K
|
Manufacturing
|
-22.27%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.41
0.37%
1M
|
Health Technology
|
-5.11%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$128.31
2.44%
2.2M
|
Health Technology
|
29.39%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
News
|
$97.31
2.3%
2.3M
|
Health Technology
|
-1.21%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$150.09
0.65%
3.9M
|
Health Technology
|
-4.39%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$741.37
1.37%
800K
|
Health Technology
|
24.67%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
|
-2.03%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
News
|
$170.19
1.37%
1.6M
|
Health Technology
|
13.6%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.85
1.49%
920K
|
Health Technology
|
1.21%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-14.22%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
News
|
$273.38
0.54%
790K
|
Health Technology
|
0.22%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
Published:
2023-12-04
(Crawled : 11:00)
- prnewswire.com
IDYA
|
News
|
$39.195
4.27%
170K
|
Health Technology
|
18.84%
|
O:
-0.09%
H:
3.48%
C:
2.56%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-13.78%
|
O:
-0.46%
H:
1.53%
C:
1.36%
ide397
trodelvy
bladder
cancer
sciences
collaboration
study
Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published:
2023-11-29
(Crawled : 15:30)
- prnewswire.com
VTRS
|
News
A
|
$11.365
1.02%
1.6M
|
Health Technology
|
23.09%
|
O:
0.11%
H:
0.44%
C:
-0.22%
JNJ
|
News
|
$150.09
0.65%
3.9M
|
Health Technology
|
-1.51%
|
O:
-0.04%
H:
0.0%
C:
0.0%
UTHR
|
$236.19
0.91%
150K
|
Health Technology
|
1.59%
|
O:
0.35%
H:
1.23%
C:
0.38%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-10.15%
|
O:
0.46%
H:
0.8%
C:
0.51%
research
hypertension
market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published:
2023-11-17
(Crawled : 16:00)
- prnewswire.com
JNJ
|
News
|
$150.09
0.65%
3.9M
|
Health Technology
|
-0.26%
|
O:
0.78%
H:
0.0%
C:
0.0%
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
|
-3.34%
|
O:
0.69%
H:
0.06%
C:
-0.68%
ABBV
|
News
|
$170.19
1.37%
1.6M
|
Health Technology
|
21.41%
|
O:
0.01%
H:
0.0%
C:
0.0%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-10.16%
|
O:
0.5%
H:
0.82%
C:
0.75%
reach
research
hiv
market
ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP
Published:
2023-11-15
(Crawled : 11:00)
- prnewswire.com
ACLX
|
$55.43
6.6%
160K
|
|
9.54%
|
O:
9.54%
H:
4.92%
C:
-3.87%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-10.4%
|
O:
-0.66%
H:
1.65%
C:
1.09%
partnership
expansion
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
690K
|
Manufacturing
|
-21.62%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.72
0.12%
110K
|
Health Technology
|
24.07%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.41
0.37%
1M
|
Health Technology
|
-2.12%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.975
6.3%
190K
|
Health Technology
|
597.36%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
News
|
$170.19
1.37%
1.6M
|
Health Technology
|
17.84%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
|
$3.815
1.19%
410K
|
Health Technology
|
46.12%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
News
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-16.51%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$23.405
2.34%
850K
|
Health Technology
|
8.8%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
Global HIV Diagnostics Market Predicted to Reach $1.5 Billion by 2030, with a CAGR of 5.5%
Published:
2023-10-25
(Crawled : 18:00)
- prnewswire.com
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
|
-12.44%
|
O:
-0.18%
H:
1.34%
C:
1.05%
GILD
|
$67.25
0.45%
2M
|
Health Technology
|
-14.33%
|
O:
-0.31%
H:
0.89%
C:
0.62%
reach
global
hiv
diagnostics
market
← Previous
1
2
3
4
5
6
7
Next →
Gainers vs Losers
87%
13%
Top 10 Gainers
MTTR
|
News
M
|
$4.64
166.67%
18M
|
AGBA
|
$2.61
108.8%
41M
|
Finance
CZOO
|
$9.32
86.77%
18M
|
EDBL
|
News
|
$6.7
78.19%
1.7M
|
OPRT
|
News
|
$3.37
49.78%
8.9M
|
Finance
MTC
|
$2.14
37.18%
4.9M
|
Technology Services
VNRX
|
$0.8
33.33%
2.9M
|
Health Technology
MLEC
|
$1.79
27.86%
2.6M
|
n/a
PALI
|
$6.29
27.59%
22M
|
Manufacturing
MCRB
|
$0.7902
26.51%
6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.